Meridian Bioscience
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Meridian Bioscience sits in the top decile of US sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count).
Meridian Bioscience: 19 sponsored US clinical trials, none currently recruiting.
Meridian Bioscience sponsors 19 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 16 completed. 4 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Suspicion of Being Infected With H.Pylori, with 1 trials.
Top-decile sponsor footprint
Meridian Bioscience ranks in the top decile of sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
19 total, page 1 of 1
Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol
NCT05681156
Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
NCT03611101
Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.
NCT03422341
Detection of Cytomegalovirus Virus in Neonates
NCT03251261
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17
NCT03462576
Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics
NCT02905825
Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains
NCT02968758
Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains
NCT02718157
Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection
NCT02528721
Detection of Mycoplasma Pneumoniae
NCT02511262
BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH
NCT02314026
Assessing Portal Hypertension With Methacetin Breath Test
NCT02143778
Detection of Chlamydia (CT) and Gonorrhea (NG)
NCT02055742
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
NCT02084160
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
NCT02010112
Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection
NCT01650831
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
NCT00375011
BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis
NCT00736840
BreathID Multi-center HCV Liver Breath Test Study
NCT00350714
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 4 |
Therapeutic Areas
How the Meridian Bioscience archive is shaped
19 indexed studies, none listed as recruiting (0% open); 16 completed (84%).
Phase mix: 4 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Suspicion of Being Infected With H.Pylori (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Meridian Bioscience: archived-pipeline peers nationwide
Peers matched on 19 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Meridian Bioscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 19 archived trials
- Almirall, S.A. · 19 trials · 5% recruiting
- Bastyr University · 19 trials · 11% recruiting
- Church & Dwight Company · 19 trials · 0% recruiting
- Cordis US · 19 trials · 5% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Meridian Bioscience page
19 registered trials is a research-attention snapshot, not an endorsement of Meridian Bioscience or any single study.
- None of Meridian Bioscience's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Suspicion of Being Infected With H.Pylori is the condition Meridian Bioscience studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Suspicion of Being Infected With H.Pylori trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Meridian Bioscience pipeline card: 19 registered trials from official public datasets.Report a data error.